XASE
BESS
Market cap4mUSD
Sep 23, Last price
2.80USD
1D
0.00%
1Q
-29.47%
Jan 2017
1,300.00%
Name
Bitech Technologies Corp
Chart & performance
P/E
103.03
P/S
8.06
EPS
0.03
Div yield, %
—
Shrs. gr., 5y
-92.16%
Rev. gr., 5y
152.39%
Revenues
3m
Net income
210k
P
CFO
394k
+105.80%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Black Titan Corporation was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. The company offers human capital management solutions and is also focused on strategic expansion into the digital asset and blockchain sectors.
Key people
William F. Donovan
Chairman of the Board, President, Chief Executive Officer · since 2017
Peter L. Dalrymple
Director · since 2014
Jerry Bratton
Independent Director · since 2010
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑07 | 2024‑12 | 2024‑07 | 2023‑12 | 2023‑07 | 2022‑12 | 2022‑07 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||